Clinical Summary of Safety and Efficacy of CT-guided Micro wave Ablation in 38 Cases of Lung Cancer
Objective:The purpose of this study was to investigate the safety and short-term efficacy of CT-guided microwave ablation(MWA)in the treatment of lung cancer.Methods:The data of 38 patients with lung cancer who underwent CT-guided MWA treatment in the Department of Thoracic Surgery of the 962 Hospital of the Joint Logistics Support Force from January 1,2023 to December 31,2023 were selected.Among them,31(81.6％)were males,with an average age of 44.2±14.3 years and an average tumor size of 13.1±5.5 mm.Tumors were located in the right upper lobe in 9 cases(23.7％),the right middle lobe in 7 cases(18.4％),the right lower lobe in 6 cases(15.8％),the left upper lobe in 10 cases(26.3％),and the left lower lobe in 6 cases(15.8％).The clinical data,complete ablation rate,short-term efficacy and complications were retrospectively analyzed to evaluate the safety and short-term efficacy of CT-guided MWA in the treatment of lung cancer.Results:A total of 38 pulmonary tumors were ablated for 38 times,all of which achieved complete ablation with a success rate of 100％.The average postoperative follow-up was 10.2±2.9 months,and there was no recurrence during the follow-up.The imaging outcomes was fibrosis in 29 cases(76.3％),complete disappearance in 7 cases(18.4％),and cavity in 2 cases(5.3％).The most common adverse reaction was pain(18 cases(47.4％).The most common complication was pneumothorax,which occurred in 12 of 38 patients(31.6％),of which 11 were localized pneumothorax,requiring only clinical observation.Only one serious complication was massive pneumothorax,which was cured by closed thoracic drainage,and no death occurred.Conclusion:CT-guided MWA is an effective local treatment for lung cancer with good safety and short-term efficacy.
万方数据
维普
